- Home
- ANVS
ANVS
Annovis Bio Inc.
as 12-18-2024 9:46am EST
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for advanced AD.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | MALVERN |
| Market Cap: | 92.6M | IPO Year: | 2020 |
| Target Price: | $29.67 | AVG Volume (30 days): | 294.5K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.97 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.53 - $22.49 | Next Earning Date: | 11-08-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Annovis Bio Inc. News
ANVS Breaking Stock News: Dive into ANVS Ticker-Specific Updates for Smart Investing
GlobeNewswire
13 days ago
Annovis CEO Showcases Groundbreaking Advances in Neurodegenerative Disease Treatment on Today’s Marketplace
GlobeNewswire
23 days ago
Annovis to Host Year-End Investor Webcast on December 11, 2024
GlobeNewswire
a month ago
Annovis Invited to Present at National Institute on Aging Workshop on Dementia with Lewy Bodies (DLB)
GlobeNewswire
a month ago
Annovis Bio Reports Third Quarter Financial Results and Provides Business Update
Simply Wall St.
a month ago
Will Annovis Bio (NYSE:ANVS) Spend Its Cash Wisely?
GlobeNewswire
a month ago
Annovis Bio Appoints Matthew Peterson, Ph.D., as Senior Clinical Scientist
GlobeNewswire
2 months ago
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Dr. Maria Maccecchini, CEO of Annovis Bio
MT Newswires
2 months ago
Maxim Upgrades Annovis Bio to Buy From Hold, Price Target is $25
Compare ANVS vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ANVS Annovis Bio Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.